Ontario's Human Health Technology and Bioscience Industry gets its 'Groove Back'

May 2012 - On the heels of gloomy economic forecasts for Ontario such as those put forward by the recently- released Drummond Commission on the Reform of Ontario’s Public Service, Ontarians have been alerted that ways must be found to replace the province’s declining manufacturing base if it is to return to a position of economic advantage relative to the rest of Canada.

OBEST strategy was launched to stop the downturn in the human health and biotechnology sector and take up the challenge of pivoting Ontario’s economy towards renewed prosperity and growth. OBEST recognized the need to take action in order to ensure Ontario does not lose the opportunity for building a globally-recognized bioscience sector that develops and exports new products and services capable of addressing global healthcare priorities.

Click here to view the full article in PDF format.